by | Mar 31, 2022 | Science
Brief Communication https://doi.org/10.1038/s41591-018-0338-6 Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome Olaya Santiago-Fernández1, Fernando G. Osorio1, Víctor Quesada 1,2, Francisco Rodríguez1, Sammy Basso1, Daniel Maeso1,...
